ALXO
NASDAQ
$1.92
Alx Oncology Holdings Inc (ALXO)
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. The company is headquartered in Burlingame, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $4.60 (+139.58%)
Market Cap
$273M
Free Cash Flow Yield
-28.68%
Beta (5Y)
1.09
Price Chart
Valuation
Market Cap$273M
P/S5085.96
P/B1.78
Profitability
Gross Profit (TTM)$107K
EBITDA-$91M
EPS-$1.45
Financial Health
Debt-to-Equity5.6%
Free Cash Flow Yield-28.68%
Growth & Risk
FCF 5Y CAGR+18.86%
Beta (5Y)1.09
Sharpe Ratio1.68